Doxorubicin Hydrochloride Injection, Solution
Product Images NDC 63323-883

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Doxorubicin Hydrochloride (NDC 63323-883). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pbox (Doxorubicin5mlcarton)

Label for Doxorubicin Hydrochloride Injection, USP, showing a strength of 10 mg per 5 mL (2 mg per mL). The label indicates the product is for intravenous use only, preservative free, and comes in a 5 mL single dose vial. The labeler is Fresenius Kabi USA, LLC.*

FDA Label Image

Vial (Doxorubicin5mlvial)

Doxorubicin Hydrochloride Injection, USP 2 mg/mL in a 5 mL single dose vial. The label states the concentration as 10 mg per 5 mL and indicates it is preservative free and for intravenous use only. The product is prescription only and labeled by Fresenius Kabi USA, LLC.*

FDA Label Image

Pbox (Doxo100mlpbox)

Label for Doxorubicin Hydrochloride Injection, USP, 200 mg per 100 mL (2 mg per mL) intravenous solution. The vial is a 100 mL multiple dose container. It is preservative free and labeled for prescription use only. Manufactured by Fresenius Kabi USA, LLC.*

FDA Label Image

Vial (Doxo100mlvial)

Doxorubicin Hydrochloride Injection, USP label showing a concentration of 200 mg per 100 mL (2 mg per mL). The label indicates it is preservative-free, for intravenous use only, and packaged in a 100 mL multiple dose vial. The label also states Rx only.*

FDA Label Image

Structure (Doxorubicin Hydrochloride Injection Usp Figure 1 Doxoru Stru)

Chemical structure of Doxorubicin Hydrochloride illustrating its molecular composition, including aromatic rings, hydroxyl groups, and a hydrochloride component.*

FDA Label Image

Figure-1 (Doxorubicin Hydrochloride Injection Usp Figure 2 Doxy Figure 1)

A forest plot figure titled "Meta-analysis of Disease-Free Survival" displaying hazard ratios with 95% confidence intervals for six clinical trials comparing Doxorubicin-based treatments versus CMF. The plot includes individual study results and a combined summary diamond indicating overall effect, with a boundary marking non-inferiority with CMF at 0.76 on the hazard ratio scale.*

FDA Label Image

Figure-2 (Doxorubicin Hydrochloride Injection Usp Figure 3 Doxy Figure 2)

A forest plot titled 'Figure 2. Meta-analysis of Overall Survival' presenting hazard ratios (with 95% confidence intervals) comparing Doxorubicin-based treatment against CMF across six studies. The x-axis ranges from 0 to 2, with a vertical reference line at 1; the plot shows individual study effect sizes and a combined diamond estimate.*

FDA Label Image

Logo (Fklz Address)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.